Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 312.50 | 169.63 | 371.00 | 280.00 | 1.3250 | 1.9516 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 312.50 | 169.63 | 117.00 | 280.00 | 0.4179 | -0.4017 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 312.50 | 169.63 | 233.00 | 280.00 | 0.8321 | 0.5512 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 169.63 | 300.00 | 280.00 | 1.0714 | 1.2002 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 312.50 | 169.63 | 259.00 | 280.00 | 0.9250 | 0.7956 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 312.50 | 169.63 | 160.00 | 280.00 | 0.5714 | -0.0776 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 312.50 | 169.63 | 180.00 | 280.00 | 0.6429 | 0.0856 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 312.50 | 169.63 | 263.00 | 280.00 | 0.9393 | 0.8340 |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 298.00 | 280.00 | 1.0643 | 1.1800 | |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 2.00 | 280.00 | 0.0071 | -0.9979 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 2.00 | 691.00 | 0.0029 | -0.9954 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 363.00 | 691.00 | 0.5253 | 0.0246 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 724.00 | 691.00 | 1.0478 | 1.0993 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 625.00 | 354.63 | 353.00 | 691.00 | 0.5109 | -0.0048 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 625.00 | 354.63 | 639.00 | 691.00 | 0.9248 | 0.8439 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 625.00 | 354.63 | 345.00 | 691.00 | 0.4993 | -0.0282 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 625.00 | 354.63 | 318.00 | 691.00 | 0.4602 | -0.1071 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 625.00 | 354.63 | 672.00 | 691.00 | 0.9725 | 0.9429 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 625.00 | 354.63 | 957.00 | 691.00 | 1.3849 | 1.8054 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 1158.00 | 691.00 | 1.6758 | 2.4200 | |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 625.00 | 354.63 | 884.00 | 691.00 | 1.2793 | 1.5834 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 625.00 | 354.63 | 1023.00 | 691.00 | 1.4805 | 2.0067 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 625.00 | 354.63 | 616.00 | 691.00 | 0.8915 | 0.7749 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 625.00 | 354.63 | 752.00 | 691.00 | 1.0883 | 1.1838 |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 625.00 | 354.63 | 334.00 | 691.00 | 0.4834 | -0.0604 |